product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
MCM2 (D7G11) XP® Rabbit mAb
catalog :
3619P
quantity :
40 ul
price :
135 USD
clonality :
monoclonal
host :
rabbit
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry, chromatin immunoprecipitation
citations: 3
Published Application/Species/DilutionReference
  • western blot; human; fig 7
Graindorge D, Martineau S, Machon C, Arnoux P, Guitton J, Francesconi S, et al. Singlet Oxygen-Mediated Oxidation during UVA Radiation Alters the Dynamic of Genomic DNA Replication. PLoS ONE. 2015;10:e0140645 pubmed publisher
  • flow cytometry; mouse
Marshall G, Deleyrolle L, Reynolds B, Steindler D, Laywell E. Microglia from neurogenic and non-neurogenic regions display differential proliferative potential and neuroblast support. Front Cell Neurosci. 2014;8:180 pubmed publisher
Kuno T, Hatano Y, Tomita H, Hara A, Hirose Y, Hirata A, et al. Organomagnesium suppresses inflammation-associated colon carcinogenesis in male Crj: CD-1 mice. Carcinogenesis. 2013;34:361-9 pubmed publisher
product information
SKU :
3619P
Product-Name :
MCM2 (D7G11) XP® Rabbit mAb
Size :
40 ul
Price-(USD) :
135 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Chromatin Immunoprecipitation
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
125
Host :
Rabbit
Target :
MCM2
Primary-Protein :
MCM2
Alt-Names :
BM28,CCNL1,CDCL1,D3S3194,DNA replication licensing factor MCM2,KIAA0030,MCM2,MCM2 minichromosome maintenance deficient 2, mitotin,MGC10606,MITOTIN,Minichromosome maintenance protein 2 homolog,Nuclear protein BM28,cdc19,cell devision cycle-like 1,cyclin-like 1,minichromosome maintenance complex component 2,minichromosome maintenance deficient 2 (mitotin)
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.